News and Events

Latest News

Jul 13, 2023

The NIMML Institute Announces Publication of a Study in Inflammatory Bowel Diseases

Jun 20, 2023

NIMML Launches A.I. Powered TITAN-X Platform to Accelerate Development of Precision Immunology Therapeutics

May 22, 2023

The NIMML Institute Launches New Tool for Rapidly Analyzing Host Metabolic Profiles from Global Transcriptomics Datasets

May 17, 2023

NIMML Institute's TITAN-X Drug Development Platform Empowers NImmune Biopharma's Global Pivotal Phase 3 Clinical Trials for Omilancor in Ulcerative Colitis

See Older News